Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07483203 · ClinicalTrials.gov registry record
A Study Of Clinical Implications Of Pulmonary Vascular Disease In Valvular Heart Disease
A clinical trial, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 600
- Enrollment target
NCT07483203: Recruiting study, sponsored by Mayo Clinic.
NCT07483203 is a clinical trial that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 600 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07483203 is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 600 participants
- Enrollment target
Study Summary
The purpose of this study is to characterize pulmonary hemodynamic profiles, with a focus on PVR subtypes, in patients with left-sided valvular heart disease undergoing aortic or mitral valve intervention, and to identify patterns predicting reversibility of TR and RV dysfunction.
Primary Outcome
Tricuspid Regurgitation (TR) reduction will be defined as ≥1 grade reduction
Interventions
- DIAGNOSTIC_TEST Echocardiogram
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2026-04-28 |
| Est. Completion | 2028-05 |
What NCT07483203 shows while recruiting
NCT07483203 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Echocardiogram is the first listed.
NCT07483203 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07483203 about?
NCT07483203 is a clinical study titled "A Study Of Clinical Implications Of Pulmonary Vascular Disease In Valvular Heart Disease". The purpose of this study is to characterize pulmonary hemodynamic profiles, with a focus on PVR subtypes, in patients with left-sided valvular heart disease undergoing aortic or mitral valve intervention, and to identify patterns predicting reversibility of TR and RV dysfunction.
What is the current status of trial NCT07483203?
This trial is currently recruiting. The enrollment target is 600 participants. The study started on 2026-04-28. Estimated completion is 2028-05.
What interventions are being tested in trial NCT07483203?
The interventions under investigation include: Echocardiogram (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07483203?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI